About Zinc finger CW-type PWWP domain protein 2
Zinc finger CW-type PWWP domain protein 2 (ZCWPW2) is a protein
from Homo sapiens identified by UniProt accession
Q504Y3, 356 residues long.
MolForge cross-references it against 0 known binders and
19 disease associations.
Target properties
| Protein name | Zinc finger CW-type PWWP domain protein 2 |
| UniProt accession | Q504Y3 |
| Gene | ZCWPW2 |
| Organism | Homo sapiens |
| Length | 356 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (19)
Diseases linked to this target (Open Targets).
- lymphocyte count · score 0.36
- neutrophil percentage of leukocytes · score 0.31
- Red cell distribution width · score 0.30
- lymphocyte percentage of leukocytes · score 0.28
- platelet-to-lymphocyte ratio · score 0.25
- multiple sclerosis · score 0.15
- systemic lupus erythematosus · score 0.12
- Epstein Barr virus nuclear antigen 1 IgG measurement · score 0.10
- mathematical ability · score 0.07
- periodontal measurement · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q504Y3-F1 | alphafold | PREDICTED | 72.45 | — |
Amino-acid sequence (356 residues)
MDKEKLDVKI EYCNYAMDSS VENMYVNKVW VQCENENCLK WRLLSSEDSA KVDHDEPWYC FMNTDSRYNN CSISEEDFPE ESQLHQCGFK IVYSQLPLGS LVLVKLQNWP SWPGILCPDR FKGKYVTYDP DGNVEEYHIE FLGDPHSRSW IKATFVGHYS ITLKPEKCKN KKKWYKSALQ EACLLYGYSH EQRLEMCCLS KLQDKSETHD KVAALVKKRK QTSKNNIEKK KPKFRKRKRK AILKCSFENV YSDDALSKEN RVVCETEVLL KELEQMLQQA LQPTATPDES EEGHGEEINM GEKLSKCSPE APAGSLFENH YEEDYLVIDG IKLKAGECIE DITNKFKEID ALMSEF
Explore Zinc finger CW-type PWWP domain protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets